Luxist Web Search

Search results

1. Results From The WOW.Com Content Network

2. How one state is trying to make weight loss drugs cheaper - AOL

   www.aol.com/news/one-state-trying-weight-loss...

   Weight loss drugs aren't covered by insurance for North Carolina's state employees. The state is negotiating with drugmakers Eli Lilly and Novo Nordisk to try to lower the costs.

3. Surprise: Eli Lilly Is Racing Toward Yet Another Blockbuster

   www.aol.com/surprise-eli-lilly-racing-toward...

   In the first quarter, Eli Lilly's revenue increased by 26% year over year to $8.8 billion. While not the most famous names in Eli Lilly's portfolio, medicines such as cancer drug Verzenio and ...

4. Weight-loss drug drives Eli Lilly to raise 2024 sales ... - AOL

   www.aol.com/news/eli-lilly-lifts-profit-view...

   Eli Lilly raised both ends of its 2024 revenue forecast by $2 billion and now expects $42.4 billion to $43.6 billion for the year. The drugmaker also raised its annual profit forecast by $1.30 per ...

5. Eli Lilly and Company - Wikipedia

   en.wikipedia.org/wiki/Eli_Lilly_and_Company

   Eli Lilly and Company is an American pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries. The company was founded in 1876 by Eli Lilly, a pharmaceutical chemist and Union Army veteran of the American Civil War for whom the company was later named.

6. Annual enrollment - Wikipedia

   en.wikipedia.org/wiki/Annual_enrollment

   Annual enrollment. In the United States, annual enrollment (also known as open enrollment or open season) is a period of time, usually but not always occurring once per year, when employees of companies and organizations, including the government, [1] may make changes to their elected employee benefit options, such as health insurance.

7. Eli Lilly reports $2 billion from Mounjaro, Zepbound in Q1 ...

   www.aol.com/finance/eli-lilly-reports-2-billion...

   April 30, 2024 at 10:23 AM. Eli Lilly ( LLY) missed Wall Street consensus estimates on Mounjaro sales for the first quarter of the year, but its GLP-1 products, including Zepbound, still ...